Jill Feldman: The Most Important Conversations Oncologists Have with Patients and Families Aren’t Data-Driven
Jill Feldman, Lung Cancer Patient and Advocate, and Co-Founder of EGFR Resisters, shared on X:
“The most important conversations oncologists have with patients and families aren’t data-driven.
Lung Cancer Rx episode 2 is live. We delve into one of the most important (and often overlooked) aspects of lung cancer care: conversations – not just about treatment options, but also about values, fears, side effects, and what truly matters to patients and their families.
Empowered choices mean more than just picking a treatment – they are deeply personal. Patients and their families deserve to be fully informed so that treatment decisions reflect their values, goals, and lives.
Grateful to Drs. Eric K. Singhi, Aakash Desai and Fawzi Abu Rous for making space for these critical, person-centered conversations.”
More posts featuring Jill Feldman.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023